AsiaTIDES: Oligonucleotide and Peptide Therapeutics | Tokyo, Japan

Website https://go.evvnt.com/355503-0?pid=4800 | Edit Freely

Category Education

Deadline: February 25, 2019 | Date: February 26, 2019-February 28, 2019

Venue/Country: Hilton Tokyo Bay, 1-8 Maihama, Urayasu-shi, 279-00, Japan

Updated: 2019-01-30 13:49:41 (GMT+9)

Call For Papers - CFP

AsiaTIDES 2019 keynote presentation lineup:

1) The Discovery of Semaglutide – A Journey from Ala Scan to Structural Design of GLP-1 Analogues

- Jesper Lau, PhD.,Vice President, Protein and Peptide Chemistry at Novo Nordisk A/S

2) New Strategies and Technologies in Oligonucleotide Therapeutic Development

- Thazha P. Prakash, PhD.,Director, Medicinal Chemistry at Ionis Pharmaceuticals

3) The Chemistry behind Approved Oligonucleotide Therapeutics

- Muthiah (Mano) Manoharan, PhD., Senior Vice President of Drug Discovery at Alnylam Pharmaceuticals, Inc.

4) From Stereopurity to Precision Medicine: Optimizing the Properties of Antisense Nucleic Acid Therapeutics

- Chandra Vargeese, PhD., SVP, Head of Drug Discovery at WAVE Life Sciences

URLs:

Tickets https://go.evvnt.com/355503-2?pid=4800

Brochure https://go.evvnt.com/355503-3?pid=4800

Prices:

Conference Pass + Pre-Conference Workshop: USD 3023.0

Conference Pass: USD 2375.0

Speakers: Jesper Lau, PhD., Novo Dordisk A/S, Thazha P. Prakash, Ph.D., Ionis Pharmaceuticals , Muthiah (Mano) Manoharan, PhD., Alnylam Pharmaceuticals, Inc, Chandra Vargeese, PhD., WAVE Life Sciences

Time: 9:00 am - 5:00 pm